Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine contrast-enhanced ultrasound guidelines: Multiparametric imaging and EUS-guided sampling in rare pancreatic tumors. Benign mesenchymal pancreatic tumors

Author:

Möller Kathleen1,Batali Alina2,Jenssen Christian3,Braden Barbara4,Hocke Michael5,On Wei6,Everett Simon M.6,Dong Yi7,Ge Nan8,Sun Siyu8,Gerber Michael1,Faiss Siegbert1,Srivastava David9,de Robertis Riccardo10,D´Onofrio Mirko10,Misselwitz Benjamin9,Dietrich Christoph F.2

Affiliation:

1. Sana Hospital Lichtenberg, Medical Department I/Gastroenterology, Berlin, Germany

2. Department Allgemeine Innere Medizin der Kliniken (DAIM) Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland

3. Krankenhaus Märkisch-Oderland, Department of Internal Medicine, Strausberg, Germany; Brandenburg Institute for Clinical Ultrasound (BICUS) at Medical University Brandenburg, Neuruppin, Germany

4. Translational Gastroenterology Unit, Oxford University Hospitals, Oxford, United Kingdom; and Medical Department B, University Muenster, Germany

5. Medical Department, Helios Klinikum Meiningen, Germany

6. Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

7. Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

8. Department of Endoscopy Center, Shengjing Hospital of China Medical University, Liaoning Province, China

9. Inselspital, University Hospital of Bern, Switzerland

10. Department of Radiology, University of Verona, Verona, Italy.

Abstract

ABSTRACT The focus of the review is on primary benign mesenchymal pancreatic tumors and their imaging appearance. These tumors are extremely rare. Usually, they are not diagnosed until postoperative histology is available, and so even benign tumors have undergone extensive pancreatic resection. The very limited data on abdominal and EUS findings including contrast-enhanced techniques of these pancreatic lesions are summarized here. Case reports will be presented for some of these rare tumors with application of modern ultrasound and endosonographic techniques.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3